{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:48:55Z","timestamp":1782132535536,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41366-026-02067-6","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:04:42Z","timestamp":1775045082000},"page":"1299-1309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between metabolic signatures of predicted VAT mass and risk of MASLD and other chronic liver diseases"],"prefix":"10.1038","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1176-7200","authenticated-orcid":false,"given":"Shi-Ao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Fei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Hui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Fei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2706-9599","authenticated-orcid":false,"given":"Xian-Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73:691\u2013702.","journal-title":"Gut"},{"key":"2067_CR2","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2147\/RMHP.S481401","volume":"17","author":"O Alqudah","year":"2024","unstructured":"Alqudah O, Alshahwan HF, Alsamhouri JF, Yamin S, Kaffaf A, Alassaf M, et al. Metabolic dysfunction-associated steatotic liver disease MASLD: Jordan\u2019s perspective based on knowledge and attitude determinants. Risk Manag Healthc Policy. 2024;17:2483\u201391.","journal-title":"Risk Manag Healthc Policy"},{"key":"2067_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/HEP.0000000000000786","volume":"82","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang L, Dong B. Molecular mechanisms in MASLD\/MASH-related HCC. Hepatology. 2024;82:1303\u201324.","journal-title":"Hepatology"},{"key":"2067_CR4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324.","journal-title":"Lancet"},{"key":"2067_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2067_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","volume":"29","author":"SA Harrison","year":"2023","unstructured":"Harrison SA, Allen AM, Dubourg J, Noureddin M, Alkhouri N. Challenges and opportunities in NASH drug development. Nature medicine. 2023;29:562\u201373.","journal-title":"Nature medicine"},{"key":"2067_CR7","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47\u201364.","journal-title":"J Hepatol"},{"key":"2067_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.22350","volume":"48","author":"D van der Poorten","year":"2008","unstructured":"van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48:449\u201357.","journal-title":"Hepatology"},{"key":"2067_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115925","volume":"218","author":"M Meroni","year":"2023","unstructured":"Meroni M, Chiappori F, Paolini E, Longo M, De Caro E, Mosca E, et al. A novel gene signature to diagnose MASLD in metabolically unhealthy obese individuals. Biochem Pharmacol. 2023;218:115925.","journal-title":"Biochem Pharmacol"},{"key":"2067_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41577-024-01103-8","volume":"25","author":"H Tilg","year":"2025","unstructured":"Tilg H, Ianiro G, Gasbarrini A, Adolph TE. Adipokines: masterminds of metabolic inflammation. Nat Rev Immunol. 2025;25:250\u201365.","journal-title":"Nat Rev Immunol"},{"key":"2067_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3390\/ijms22031160","volume":"22","author":"G Raja","year":"2021","unstructured":"Raja G, Gupta H, Gebru YA, Youn GS, Choi YR, Kim HS, et al. Recent advances of microbiome-associated metabolomics profiling in liver disease: principles, mechanisms, and applications. Int J Mol Sci. 2021;22:1160.","journal-title":"Int J Mol Sci"},{"key":"2067_CR12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s12276-021-00614-x","volume":"53","author":"G Park","year":"2021","unstructured":"Park G, Jung S, Wellen KE, Jang C. The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease. Exp Mol Med. 2021;53:809\u201322.","journal-title":"Exp Mol Med"},{"key":"2067_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52310-9","volume":"15","author":"S Zhang","year":"2024","unstructured":"Zhang S, Wang Z, Wang Y, Zhu Y, Zhou Q, Jian X, et al. A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank. Nat Commun. 2024;15:8081.","journal-title":"Nat Commun"},{"key":"2067_CR14","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3390\/jcm14082750","volume":"14","author":"M Pecani","year":"2025","unstructured":"Pecani M, Andreozzi P, Cangemi R, Corica B, Miglionico M, Romiti GF, et al. Metabolic syndrome and liver disease: re-appraisal of screening, diagnosis, and treatment through the paradigm shift from NAFLD to MASLD. J Clin Med. 2025;14:2750.","journal-title":"J Clin Med"},{"key":"2067_CR15","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1210\/clinem\/dgaa693","volume":"106","author":"L Lind","year":"2021","unstructured":"Lind L, Salihovic S, Ris\u00e9rus U, Kullberg J, Johansson L, Ahlstr\u00f6m H, et al. The plasma metabolomic profile is differently associated with liver fat, visceral adipose tissue, and pancreatic fat. J Clin Endocrinol Metab. 2021;106:e118\u2013e29.","journal-title":"J Clin Endocrinol Metab"},{"key":"2067_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1148\/radiol.2021204288","volume":"301","author":"J Starekova","year":"2021","unstructured":"Starekova J, Hernando D, Pickhardt PJ, Reeder SB. Quantification of liver fat content with CT and MRI: state of the art. Radiology. 2021;301:250\u201362.","journal-title":"Radiology"},{"key":"2067_CR17","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779.","journal-title":"PLoS Med"},{"key":"2067_CR18","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41591-019-0563-7","volume":"25","author":"T Karlsson","year":"2019","unstructured":"Karlsson T, Rask-Andersen M, Pan G, H\u00f6glund J, Wadelius C, Ek WE, et al. Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease. Nat Med. 2019;25:1390\u20135.","journal-title":"Nat Med"},{"key":"2067_CR19","doi-asserted-by":"publisher","first-page":"e2320222","DOI":"10.1001\/jamanetworkopen.2023.20222","volume":"6","author":"MS Vell","year":"2023","unstructured":"Vell MS, Loomba R, Krishnan A, Wangensteen KJ, Trebicka J, Creasy KT, et al. Association of statin use with risk of liver disease, hepatocellular carcinoma, and liver-related mortality. JAMA Netw Open. 2023;6:e2320222.","journal-title":"JAMA Netw Open"},{"key":"2067_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12933-024-02284-1","volume":"23","author":"HW Chen","year":"2024","unstructured":"Chen HW, Liu K, Cao BF, Zhong Q, Zhou R, Li LH, et al. Combined associations of visceral adipose tissue and adherence to a Mediterranean lifestyle with T2D and diabetic microvascular complications among individuals with prediabetes. Cardiovasc Diabetol. 2024;23:201.","journal-title":"Cardiovasc Diabetol"},{"key":"2067_CR21","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","journal-title":"J Hepatol"},{"key":"2067_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/hep.31726","volume":"74","author":"H Hagstr\u00f6m","year":"2021","unstructured":"Hagstr\u00f6m H, Adams LA, Allen AM, Byrne CD, Chang Y, Gr\u00f8nbaek H, et al. Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement. Hepatology. 2021;74:474\u201382.","journal-title":"Hepatology"},{"key":"2067_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jhep.2024.08.024","volume":"82","author":"Q Zhong","year":"2024","unstructured":"Zhong Q, Zhou R, Huang YN, Huang RD, Li FR, Chen HW, et al. Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases. J Hepatol. 2024;82:427\u201337.","journal-title":"J Hepatol"},{"key":"2067_CR24","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.29639","volume":"67","author":"C Caussy","year":"2018","unstructured":"Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, et al. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology. 2018;67:1348\u201359.","journal-title":"Hepatology"},{"key":"2067_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S2468-1253(21)00169-2","volume":"6","author":"T Marjot","year":"2021","unstructured":"Marjot T, Ray DW, Williams FR, Tomlinson JW, Armstrong MJ. Sleep and liver disease: a bidirectional relationship. Lancet Gastroenterol Hepatol. 2021;6:850\u201363.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2067_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04047-0","volume":"21","author":"S Lu","year":"2023","unstructured":"Lu S, Xie Q, Kuang M, Hu C, Li X, Yang H, et al. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. J Transl Med. 2023;21:192.","journal-title":"J Transl Med"},{"key":"2067_CR27","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3390\/biomedicines11102711","volume":"11","author":"Z Ding","year":"2023","unstructured":"Ding Z, Wei Y, Peng J, Wang S, Chen G, Sun J. The potential role of C-reactive protein in metabolic-dysfunction-associated fatty liver disease and aging. Biomedicines. 2023;11:2711.","journal-title":"Biomedicines"},{"key":"2067_CR28","doi-asserted-by":"publisher","first-page":"e63033","DOI":"10.7554\/eLife.63033","volume":"10","author":"H Julkunen","year":"2021","unstructured":"Julkunen H, Cicho\u0144ska A, Slagboom PE, W\u00fcrtz P. Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. Elife. 2021;10:e63033.","journal-title":"Elife"},{"key":"2067_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1467-9868.2010.00740.x","volume":"72","author":"N Meinshausen","year":"2010","unstructured":"Meinshausen N, B\u00fchlmann P. Stability Selection. J R Stat Soc Ser B Stat Methodol. 2010;72:417\u201373.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"2067_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.simpa.2021.100147","volume":"10","author":"BY Alli","year":"2021","unstructured":"Alli BY. InteractionR: an R package for full reporting of effect modification and interaction. Softw Impacts. 2021;10:100147.","journal-title":"Softw Impacts"},{"key":"2067_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12944-025-02439-3","volume":"24","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Su X, Tan H, Xiao J. Association between metabolic score for visceral fat index and BMI-adjusted skeletal muscle mass index in American adults. Lipids Health Dis. 2025;24:29.","journal-title":"Lipids Health Dis"},{"key":"2067_CR32","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1007\/s11605-019-04259-0","volume":"24","author":"SJ Yang","year":"2020","unstructured":"Yang SJ, Li HR, Zhang WH, Liu K, Zhang DY, Sun LF, et al. Visceral fat area (VFA) superior to BMI for predicting postoperative complications after radical gastrectomy: a prospective cohort study. J Gastrointest Surg. 2020;24:1298\u2013306.","journal-title":"J Gastrointest Surg"},{"key":"2067_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cen.14953","volume":"99","author":"M Tao","year":"2023","unstructured":"Tao M, Zhou G, Liu J, He M, Wang C, Luo X, et al. Visceral adipose tissue and risk of nonalcoholic fatty liver disease: a Mendelian randomization study. Clin Endocrinol (Oxf). 2023;99:370\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2067_CR34","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/hep.29578","volume":"67","author":"AJ Montano-Loza","year":"2018","unstructured":"Montano-Loza AJ, Mazurak VC, Ebadi M, Meza-Junco J, Sawyer MB, Baracos VE, et al. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant. Hepatology. 2018;67:914\u201323.","journal-title":"Hepatology"},{"key":"2067_CR35","doi-asserted-by":"publisher","first-page":"e1665","DOI":"10.1210\/clinem\/dgae021","volume":"109","author":"S Kubota","year":"2024","unstructured":"Kubota S, Yabe D. Visceral adipose tissue quality and its impact on metabolic health. J Clin Endocrinol Metab. 2024;109:e1665\u2013e6.","journal-title":"J Clin Endocrinol Metab"},{"key":"2067_CR36","doi-asserted-by":"publisher","first-page":"mjad069","DOI":"10.1093\/jmcb\/mjad069","volume":"15","author":"H Chen","year":"2024","unstructured":"Chen H, Liu Y, Liu D, Liang Y, Zhu Z, Dong K, et al. Sex- and age-specific associations between abdominal fat and non-alcoholic fatty liver disease: a prospective cohort study. J Mol Cell Biol. 2024;15:mjad069.","journal-title":"J Mol Cell Biol"},{"key":"2067_CR37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ijc.34751","volume":"154","author":"FQ Xu","year":"2024","unstructured":"Xu FQ, Xu QY, Zhu ZJ, Jin L, Ye TW, Du CF, et al. Visceral and ectopic fat are more predictively associated with primary liver cancer than overall obesity from genetic sights: a Mendelian randomization study. Int J Cancer. 2024;154:530\u20137.","journal-title":"Int J Cancer"},{"key":"2067_CR38","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/endrev\/bnaf018","volume":"46","author":"J Dong","year":"2025","unstructured":"Dong J, Dennis K, Venkatakrishnan R, Hodson L, Tomlinson JW. The impact of estrogen deficiency on liver metabolism: implications for hormone replacement therapy. Endocr Rev. 2025;46:790\u2013809.","journal-title":"Endocr Rev"},{"key":"2067_CR39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/biomedicines13040855","volume":"13","author":"I Milani","year":"2025","unstructured":"Milani I, Chinucci M, Leonetti F, Capoccia D. MASLD: prevalence, mechanisms, and sex-based therapies in postmenopausal women. Biomedicines. 2025;13:855.","journal-title":"Biomedicines"},{"key":"2067_CR40","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","volume":"23","author":"M Zamani","year":"2025","unstructured":"Zamani M, Alizadeh-Tabari S, Ajmera V, Singh S, Murad MH, Loomba R. Global prevalence of advanced liver fibrosis and cirrhosis in the general population: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2025;23:1123\u201334.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2067_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.tem.2010.01.009","volume":"21","author":"RH Unger","year":"2010","unstructured":"Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab. 2010;21:345\u201352.","journal-title":"Trends Endocrinol Metab"},{"key":"2067_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ecl.2020.02.008","volume":"49","author":"KM Gavin","year":"2020","unstructured":"Gavin KM, Bessesen DH. Sex differences in adipose tissue function. Endocrinol Metab Clin North Am. 2020;49:215\u201328.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2067_CR43","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","volume":"79","author":"BP Lee","year":"2024","unstructured":"Lee BP, Dodge JL, Terrault NA. National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature. Hepatology. 2024;79:666\u201373.","journal-title":"Hepatology"},{"key":"2067_CR44","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75:3313\u201327.","journal-title":"Cell Mol Life Sci"},{"key":"2067_CR45","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65:1109\u201323.","journal-title":"Metabolism"},{"key":"2067_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","volume":"14","author":"NL Gluchowski","year":"2017","unstructured":"Gluchowski NL, Becuwe M, Walther TC, Farese RV Jr. Lipid droplets and liver disease: from basic biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2017;14:343\u201355.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2067_CR47","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.plipres.2023.101238","volume":"91","author":"G Musso","year":"2023","unstructured":"Musso G, Saba F, Cassader M, Gambino R. Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): recent advances. Prog Lipid Res. 2023;91:101238.","journal-title":"Prog Lipid Res"},{"key":"2067_CR48","first-page":"285","volume":"10","author":"MR Ghadir","year":"2010","unstructured":"Ghadir MR, Riahin AA, Havaspour A, Nooranipour M, Habibinejad AA. The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepat Mon. 2010;10:285\u20138.","journal-title":"Hepat Mon"},{"key":"2067_CR49","doi-asserted-by":"publisher","first-page":"e231007","DOI":"10.1148\/radiol.231007","volume":"309","author":"T Xia","year":"2023","unstructured":"Xia T, Du M, Li H, Wang Y, Zha J, Wu T, et al. Association between liver MRI proton density fat fraction and liver disease risk. Radiology. 2023;309:e231007.","journal-title":"Radiology"},{"key":"2067_CR50","unstructured":"Arvind A, Osganian SA, Cohen DE, Corey KE. Lipid and lipoprotein metabolism in liver disease. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright \u00a9 2000-2025, MDText.com,Inc.; 2000."},{"key":"2067_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.athplu.2023.08.001","volume":"53","author":"M Hoekstra","year":"2023","unstructured":"Hoekstra M, Van Eck M. High-density lipoproteins and non-alcoholic fatty liver disease. Atheroscler Plus. 2023;53:33\u201341.","journal-title":"Atheroscler Plus"},{"key":"2067_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22.","journal-title":"Front Cardiovasc Med"},{"key":"2067_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1743-7075-1-12","volume":"1","author":"ES Freedland","year":"2004","unstructured":"Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond). 2004;1:12.","journal-title":"Nutr Metab (Lond)"},{"key":"2067_CR54","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/cells10051048","volume":"10","author":"O Pivovarova-Ramich","year":"2021","unstructured":"Pivovarova-Ramich O, Loske J, Hornemann S, Markova M, Seebeck N, Rosenthal A, et al. Hepatic Wnt1 inducible signaling pathway protein 1 (WISP-1\/CCN4) associates with markers of liver fibrosis in severe obesity. Cells. 2021;10:1048.","journal-title":"Cells"},{"key":"2067_CR55","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s12276-020-0438-5","volume":"52","author":"YR Shim","year":"2020","unstructured":"Shim YR, Jeong WI. Recent advances of sterile inflammation and inter-organ cross-talk in alcoholic liver disease. Exp Mol Med. 2020;52:772\u201380.","journal-title":"Exp Mol Med"},{"key":"2067_CR56","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1007\/s00018-020-03752-z","volume":"78","author":"A Kulkarni","year":"2021","unstructured":"Kulkarni A, Bowers LW. The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis. Cell Mol Life Sci. 2021;78:3423\u201342.","journal-title":"Cell Mol Life Sci"},{"key":"2067_CR57","doi-asserted-by":"publisher","first-page":"e213630","DOI":"10.1212\/WNL.0000000000213630","volume":"104","author":"HW Chen","year":"2025","unstructured":"Chen HW, Wang SA, Xu ZY, Shao ZH, Zhong Q, Wei YF, et al. Association of predicted visceral fat percentage with dementia risk in older adults: the role of genetic risk and lifestyle. Neurology. 2025;104:e213630.","journal-title":"Neurology"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02067-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02067-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02067-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:03:41Z","timestamp":1782129821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02067-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02067-6","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}